Enduring controversies in the management of hyperbilirubinemia in preterm neonates

Seminars in Fetal and Neonatal Medicine

Volumn 15, Issue 3, 2010, Pages 136-140

  Watchko, Jon F ^a   Jeffrey Maisels, M ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

Bilirubin:albumin ratio; Exchange transfusion; Extremely low birthweight; Neurodevelopmental outcome; Phototherapy; Prematurity

Indexed keywords

BILIRUBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL TRIAL; COGNITION; EXCHANGE BLOOD TRANSFUSION; HUMAN; INTELLIGENCE QUOTIENT; KERNICTERUS; NEUROTOXICITY; NEWBORN JAUNDICE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREMATURITY; PROGNOSIS; RISK ASSESSMENT;

BILIRUBIN; EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; INFANT, PREMATURE; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77953290192     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2009.12.003     Document Type: Article

References (53)

1. Jardine D.S., and Rogers K. Relationship of benzyl alcohol to kernicterus, intraventricular hemorrhage, and mortality in preterm infants. Pediatrics 83 (1989) 153-160
2. Pearlman M.A., Gartner L.M., Lee K., Morecki R., and Horoupian D.S. Absence of kernicterus in low-birth-weigth infants from 1971 through 1976: comparison with findings from 1966 and 1967. Pediatrics 62 (1978) 460-464
3. Watchko J., and Claasen D. Kernicterus in premature infants: current prevalence and relationship to NICHD phototherapy study exchange criteria. Pediatrics 93 (1994) 996-999
4. Cashore W.J. Bilirubin and jaundice in the micropremie. Clin Perinatol 27 (2000) 171-179
5. Maisels M.J., and Watchko J.F. Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 88 (2003) 459-463
6. Maisels M.J. Phototherapy - traditional and non-traditional. J Perinatol 21 (2001) S93-S97
7. O'Shea T.M., Dillard R.G., Klinepeter K.D., et al. Serum bilirubin levels, intracranial hemorrhage, and the risk of developmental problems in very low birth weight infants. Pediatrics 90 (1992) 888-892
8. Harris R.C., Lucey J.F., and MacLean J.R. Kernicterus in premature infants associated with low concentrations of bilirubin in the plasma. Pediatrics 21 (1958) pp. 875-3
9. Gartner L.M., Snyder R.N., Chabon R.S., and Bernstein J. Kernicterus: high incidence in premature infants with low serum bilirubin concentrations. Pediatrics 45 (1970) 906-917
10. Sugama S., Soeda A., and Eto Y. Magnetic resonance imaging in three children with kernicterus. Pediatr Neurol 25 (2001) 328-331
11. Okumura A., Kidokoro H., Shoji H., et al. Kernicterus in preterm infants. Pediatrics 123 (2009) e1052-e1058
12. Bhutani V.K., Johnson L.H., and Shapiro S.M. Kernicterus in sick and preterm infants (1999-2002): a need for an effective preventive approach. Semin Perinatol 28 (2004) 319-325
13. van de Bor M., van Zeben-van der Aa T.M., Verloove-Vanhorick S.P., et al. Hyperbilirubinemia in very preterm infants and neurodevelopmental outcome at two years of age: results of a national collaborative survey. Pediatrics 83 (1989) 915-920
14. Scheidt P.C., Mellitis E.D., Hardy J.B., Drage J.S., and Boggs T.R. Toxicity to bilirubin in neonates: infant development during first year in relation to maximum neonatal serum bilirubin concentration. J Pediatr 91 (1977) 292-297
15. Naeye R.L. Amniotic fluid infections, neonatal hyperbilirubinemia, and psychomotor impairment. Pediatrics 62 (1978) 497-503
16. Gkoltsiou K., Tzoufi M., Counsell S., Rutherford M., and Cowan F. Serial brain MRI and ultrasound findings: relation to gestational age, bilirubin level, neonatal neurologic status and neurodevelopmental outcome in infants at risk of kernicterus. Early Hum Dev 84 (2008) 829-838
17. Oh W., Tyson J.E., Fanaroff A.A., et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 112 (2003) 773-779
18. Govaert P., Lequin M., Swarte R., et al. Changes in globus pallidus with (pre)term kernicterus. Pediatrics 112 (2003) 1256-1263
19. Turkel S.B., Guttenberg M.E., Moynes D.R., and Hodgman J.E. Lack of identifiable risk factors for kernicterus. Pediatrics 66 (1980) 502-506
20. Kim M.H., Yoon J.J., Sher J., and Brown A.K. Lack of predictive indices in kernicterus: a comparison of clinical and pathologic factors in infants with and without kernicterus. Pediatrics 66 (1980) 852-858
21. Graziani L.J., Mitchell D.G., Kornhauser M., et al. Neurodevelopment of preterm infants: neonatal neurosonographic and serum bilirubin studies. Pediatrics 89 (1992) 229-234
22. Macgregor D., Whitfield M.F., Delcati D., and Roland E. Bilirubin and kernicterus in infants <1000 grams birth weight: a follow-up study. Pediatr Res 25 (1989) 257A
23. Brown D.R., Watchko J.F., and Sabo D. Neonatal sensorineural hearing loss associated with furosemide: a case-control study. Dev Med Child Neurol 33 (1991) 816-823
24. Hack M., Wilson-Costello D., Friedman H., Taylor G.H., Schluchter M., and Fanaroff A.A. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992-1995. Arch Pediatr Adolesc Med 154 (2000) 725-731
25. Maisels M.J. Jaundice. In: Avery G.B., Fletcher M.A., and MacDonald M.G. (Eds). Neonatology: pathology and management of the newborn (1999), J.B. Lipincott, Philadelphia 765-819
26. Rennie J.M., Sehgal A., De A., Kendall G.S., and Cole T.J. Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinemia. Arch Dis Child Fetal Neonatal Ed 94 (2009) F323-F327
27. Bryla D.A. Development, design, and sample composition. Pediatrics 75 Suppl (1985) 387-441
28. Brown A.K., Kim M.H., Wu P.Y.K., and Bryla D.A. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 75 Suppl (1985) 393-441
29. Lipsitz P.J., Gartner L.M., and Bryla D.A. Neonatal and infant mortality in relation to phototherapy. Pediatrics 75 Suppl (1985) 422-441
30. Ikonen R.S., Kuusinen E.J., Janas M.O., Koivkko M.J., and Sorto A.E. Possible etiologic factors in extensive periventricular leucomalacia of preterm infants. Acta Paediatr Scand 77 (1988) 489-495
31. Ikonen R.S., Janas M.O., Koivkko M.J., Laippala P., and Kuusinen E.J. Hyperbilirubinemia, hypocarbia and periventricular leukomalacia in preterm infants: relationship to cerebral palsy. Acta Paediatr 81 (1992) 802-807
32. Trounce J., Shaw D.E., Levine M.I., and Rutter N. Clinical risk factors and periventricular leucomalacia. Arch Dis Child 63 (1988) 17-22
33. Scheidt P.C., Bryla D.A., Nelson K.B., Hirtz D.G., and Hoffman H.J. Phototherapy for neonatal hyperbilirubinemia. Six year follow-up of the NICHD clinical trial. Pediatrics 85 (1990) 455-463
34. Scheidt P.C., Graubard B.I., Nelson K.B., et al. Intelligence at six years in relation to neonatal bilirubin level: follow-up of the National Institute of Child Health and Human Development Clinical Trial of Phototherapy. Pediatrics 87 (1991) 797-805
35. Morris B.H., Oh W., Tyson J.E., Stevenson D.K., et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med 359 (2008) 1885-1896
36. Vreman H.J., Wong R.J., and Stevenson D.K. Phototherapy: current methods and future directions. Semin Perinatol 28 (2004) 326-333
37. Wennberg R.P., Ahlfors C.E., Bhutani V.K., Johnson L.H., and Shapiro S.M. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 117 (2006) 474-485
38. McDonagh A.F., and Maisels M.J. Bilirubin unbound: déjà vu all over again. Pediatrics 117 (2006) 523-525
39. Cashore W.J., and Oh W. Unbound bilirubin and kernicterus in low birthweight infants. Pediatrics 69 (1982) 481-485
40. Nakamura H., Yonetani M., Uetani Y., Funato M., and Lee Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birth weight infants. Acta Paediatr Jpn 54 (1992) 642-647
41. Funato M., Tamai H., Shimada S., and Nakamura H. Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics 93 (1994) 50-53
42. Amin S.B., Ahlfors C.E., Orlando M.S., Dalzell L.E., Merle K.S., and Guillet R. Bilirubin and serial auditory brainstem responses in premature infants. Pediatrics 107 (2001) 664-670
43. Daood M.J., McDonagh A.F., and Watchko J.F. Calculated free bilirubin levels and neurotoxicity. J Perinatol 29 (2009) S14-S19
44. Ahlfors C.E. Criteria for exchange transfusion in jaundiced newborns. Pediatrics 93 (1994) 488-494
45. Cashore W.J. Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infants. J Pediatr 96 (1980) 521-527
46. Cashore W.J., Oh W., and Brodersen R. Reserve albumin and bilirubin toxicity index in infant serum. Acta Paediatr Scand 72 (1983) 415-419
47. Ebbesen F., and Brodersen R. Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: considerations of blood/brain bilirubin transfer equilibrium. Early Hum Dev 6 (1982) 341-355
48. Esbjorner E. Albumin binding properties in relation to bilirubin and albumin concentrations during the first week of life. Acta Paediatr Scand 80 (1991) 400-405
49. Ebbsen F., and Nyboe J. Postnatal changes in the ability of plasma albumin to bind bilirubin. Acta Paediatr Scand 72 (1983) 665-670
50. Bender G.J., Cashore W.J., and Oh W. Ontogeny of bilirubin-dinding capacity and the effect of clinical status in premature infants born at less than 1300 grams. Pediatrics 120 (2007) 1067-1073
51. Hulzebos C.V., van Imhoff D.E., Bos A.F., Ahlfors C.E., Verkade H.J., and Dijk P.H. Usefulness of the bilirubin/albumin ratio for predicting bilirubin-induced neurotoxicity in premature infants. Arch Dis Child Fetal Neonatal Ed 93 (2008) F384-F388
52. Wennberg R.P. Cellular basis of bilirubin toxicity. NY State J Med 91 (1991) 493-496
53. Watchko J.F. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromolec Med 8 (2006) 513-529